SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-301244
Filing Date
2019-11-26
Accepted
2019-11-26 16:54:04
Documents
6
Period of Report
2019-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d839891d8k.htm 8-K 29914
2 EX-2.1 d839891dex21.htm EX-2.1 264021
3 EX-10.1 d839891dex101.htm EX-10.1 68135
4 EX-10.2 d839891dex102.htm EX-10.2 73672
5 EX-10.3 d839891dex103.htm EX-10.3 112842
6 EX-10.4 d839891dex104.htm EX-10.4 17306
  Complete submission text file 0001193125-19-301244.txt   567029
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 191251871
SIC: 2834 Pharmaceutical Preparations